Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|November 15, 2017
Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regionsDörte Petit, Carole Tevi-Benissan, Joseph Woodring, et al.
Vaccines|March 28, 2024
National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and EthiopiaMaarten Jansen, Dijana Spasenoska, Mardiati Nadjib, et al.
Bulletin of the World Health Organization|August 4, 2022
Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesisChristopher P Seaman, Anna-Lea Kahn, Debra Kristensen, et al.
Vaccine|June 2, 2017
Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?Birgitte K Giersing, Anna-Lea Kahn, Courtney Jarrahian, et al.
BMC Public Health|November 27, 2025
Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countriesDijana Spasenoska, Anna-Lea Kahn, Malika Bouhenia, et al.
The Pan African Medical Journal|January 4, 2018
An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in TogoMercy Mvundura, Patrick Lydon, Abdoulaye Gueye, et al.
Vaccine|December 9, 2022
COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs)Anna-Lea Kahn, Christoph A Steffen, Louise Henaff, et al.
Vaccines|January 8, 2025
Stakeholder Consultation Workshop on the Perceived Value of Thermostable Vaccines to Relieve Program Barriers: A Case Study from Côte d'IvoireAnna-Lea Kahn, Dijana Spasenoska, Kouadio Daniel Ekra, et al.
Vaccine|October 10, 2021
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countriesBirgitte Giersing, Natasha Shah, Debra Kristensen, et al.
Plos Neglected Tropical Diseases|February 23, 2026
Country-level perspectives and priorities to guide the development of Invasive non-Typhoidal Salmonella (iNTS) vaccines: Insights from seven countriesDijana Spasenoska, Anna-Lea Kahn, Annelies Wilder-Smith, et al.
Pageof 3